MATSUKIYOCOCOKARA & CO.

Sector revisions MatsukiyoCocokara & Co.

Equities

3088

JP3869010003

Drug Retailers

Delayed Japan Exchange Other stock markets 01:35:47 09/12/2025 GMT			5-day change	1st Jan Change
2,825.00 ^JPY	-0.79%		-1.40%	+22.56%

11-13	MatsukiyoCocokara & Co. Announces Dividend for the Second Quarter Ended September 30, 2025, Payable on December 2, 2025 and Provides Year End Dividend Guidance for the Year Ending March 31, 2026	CI
11-13	MatsukiyoCocokara & Co. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2026	CI

Sector:

Location:

X axis:

Main competitors

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	MATSUKIYOCOCOKARA & CO.							12
	JD HEALTH INTERNATIONAL INC.							17
	ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED							18
	CLICKS GROUP LIMITED							8
	YIFENG PHARMACY CHAIN CO., LTD.							12
	NAHDI MEDICAL COMPANY							7
	DASHENLIN PHARMACEUTICAL GROUP CO., LTD.							8
	CORPORATIVO FRAGUA, S.A.B. DE C.V.		-		-		-	1
	GUARDIAN PHARMACY SERVICES, INC.							4
	DIS-CHEM PHARMACIES LIMITED							7
	REDCARE PHARMACY NV							8
	AL-DAWAA MEDICAL SERVICES COMPANY							7
	MEDPLUS HEALTH SERVICES LIMITED							7
	YIXINTANG PHARMACEUTICAL GROUP CO., LTD.							5
	APOTEA AB						-	1
	GENKY DRUGSTORES CO., LTD.							2
	EMPREENDIMENTOS PAGUE MENOS S.A.							7
	Average							8
	Weighted average by Cap.							13

Other Drug Retailers

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Unlock them now!